NMIBC Tumor Board: Nuances in Management w/ Dr. Mark Tyson & Dr. Sarah Psutka | Tumor Board Ep. 30

When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern treatments, biomarkers, and clinical studies have opened up new avenues for treating recurrent non-muscle invasive bladder cancer (NMIBC). The penultimate episode of the 2025 NMIBC Creator Weekend™ series features urologic oncologists Dr. Vignesh Packiam, Dr. Mark Tyson, and Dr. Sarah Psutka discussing how they navigate complex bladder cancer scenarios. --- This podcast is supported by: ⁠Ferring Pharmaceuticals https://www.ferring.com/home-classic/... --- SYNPOSIS The doctors share treatment strategies, staging processes, and post-therapy patient management techniques. They address recurrent disease, approaches to different stages of cancer, the role of biomarkers in determining treatment paths, and considerations for both high-risk and intermediate-risk patients. Additionally, the episode touches on new treatments, clinical trials, and patient quality of life post-treatment. --- TIMESTAMPS 00:00 - Introduction 02:08 - Case Study: Initial Patient Assessment 04:59 - Surgical Considerations and Techniques 10:22 - Managing Bladder Cancer Recurrence 11:15 - Treatment Options and Clinical Trials 15:12 - Advanced Treatment Strategies 28:14 - Closing Remarks and Credits --- BackTable Tumor Board is a multidisciplinary podcast for healthcare professionals that play an active role in cancer care. #ONC30 #nmibc #bladdercancer #backtable #creatorweekend #urologiconcology